Growth inhibition of A549 human lung adenocarcinoma cells by L-Canavanine is associated with p21/WAF1 induction

Japanese Journal of Cancer Research

Volumn 90, Issue 1, 1999, Pages 69-74

  Ding, Yi ^a   Matsukawa, Yoshizumi ^a,c   Naoko, Ohtani Fujita ^a   Kato, Daishiro ^a   Dao, Su ^a   Fujii, Takaaki ^a   Naito, Yuji ^a   Yoshikawa, Toshikazu ^a   Sakai, Toshiyuki ^a   Rosenthal, Gerald A ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Hyogo Institute for Oriental Medicine   (Japan)

Author keywords

Cell cycle; L Canavanine; p21 WAF1; p53; RB

Indexed keywords

CANAVANINE; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DEPHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

EID: 0033011328     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00667.x     Document Type: Article

References (33)

1. Rosenthal, G. A. Preparation and colorimetric analysis of L-canavanine. Anal. Biochem., 77, 147-151 (1977).
2. Bell, E. A., Lakey, J. A. and Polhill, R. M. Systematic significance of canavanine in the Papilionoideae (Fuboideae). Biochem. Syst. Ecol., 6, 201-212 (1978).
3. Allende, C. C. and Allende, J. E. Purification and substrate specificity of arginyl tRNA synthetase from rat liver. J. Biol. Chem., 239, 1102-1112 (1964).
4. Rosenthal, G. A. Nonprotein amino acids in the life processes of higher plants. In "Biosynthesis and Molecular Regulation of Amino Acids in Plants," ed. B. K. Singh, H. E. Flores and J. C. Shannon, pp. 249-261 (1992). American Society of Plant Physiologists, Rockville, MD.
5. Rosenthal, G. A., Lambert, J. and Hoffmann, D. Canavanine incorporation into the antibacterial proteins of the fly. Phormia terranovae (Diptera), and its effect on biological activity. J. Biol. Chem., 264, 9768-9771 (1989).
6. Rosenthal, G. A. and Dahlman, D. L. Studies of L-canavanine incorporation into insectan lysozyme. J. Biol. Chem., 266, 15684-15687 (1964).
7. Prouty, W. P., Karnovsky, M. J. and Goldberg, A. L. Degradation of abnormal proteins in Escherichia coli: formation of protein inclusions in cells exposed to amino acid analogs. J. Biol. Chem., 250, 1112-1122 (1975).
8. Prouty, W. F. Degradation of abnormal proteins in HeLa cells. J. Cell. Physiol., 88, 371-382 (1976).
9. Fong, D. and Poole, B. The effect of canavanine on protein synthesis and protein degradation IMR-90 fibroblasts. Biochim. Biophys. Acta, 696, 193-200 (1982).
10. Halban, P. A., Amherdt, M., Orci, L. and Renold, A. E. Proinsulin modified by analogues of arginine and lysine is degraded rapidly in pancreatic B-cells. Biochem. J., 219, 91-97 (1984).
11. Rosenthal, G. A. and Dahlman, D. L. L-Canavanine and protein synthesis in the tobacco hornworm Manduca sexta. Proc. Natl. Acad. Sci. USA, 83, 14-18 (1986).
12. Liaudet, L., Feihl, F., Rosselet, A., Markert, M., Hurni, J. M. and Perret, C. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent development. Clin. Sci., 90, 369-377 (1996).
13. Umans, J. G. and Samsel, R. W. L-Canavanine selectively augments contraction in aortas from endotoxemic rats. Eur. J. Pharmacol., 210, 343-346 (1992).
14. Swaffar, D. S., Ang, C. Y., Desai, P. B. and Rosenthal, G. A. Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite L-canavanine. Cancer Res., 54, 6045-6048 (1994).
15. Mattei, E., Damasi, D., Mileo, A. M., Delpino, A. and Ferrini, U. Stress response, survival and enhancement of heat sensitivity in a human melanoma cell line treated with L-canavanine. Anticancer Res., 12, 757-762 (1992).
16. Green, M. H. and Ward, J. F. Enhancement of human tumor cell killing by L-canavanine in combination with gamma-radiation. Cancer Res., 43, 4180-4182 (1983).
17. Swaffar, D. S., Ang, C. Y., Desai, P. B., Rosenthal, G. A., Thomas, D. A., Crooks, P. A. and John, W. J. Combination therapy with 5-fluorouracil and L-canavanine: in vitro and in vivo studies. Anti-cancer Drugs, 6, 586-593 (1995).
18. Thomas, D. A., Rosenthal, G. A., Gold, D. V. and Dickey, K. Growth inhibition of a rat colon tumor by L-canavanine. Cancer Res., 46, 2898-2903 (1986).
19. Ghigo, D., Arese, M., Todde, R., Vecchi, A., Silvagno, F., Costamagna, C., Dong, Q. G., Alessio, M., Heller, R., Soldi, R., Trucco, F., Garbarino, G., Pescarmona, G., Mantovani, A., Bussolino, F. and Bosia, A. Middle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase. J. Exp. Med., 181, 9-19 (1995).
20. Green, M. H., Brooks, T. L., Mendelsohn, J. and Howell, S. B. Antitumor activity of L-canavanine against L1210 murine leukemia. Cancer Res., 40, 535-537 (1980).
21. Harper, J. W. Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. The p21 cyclin-dependent kinase-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell, 75, 805-816 (1993).
22. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-704 (1993).
23. Gu, Y., Turck, C. W. and Morgan, D. O. Inhibition of cyclin-dependent kinase 2 activity in vivo by an associated 20 K regulatory subunit. Nature, 366, 707-710 (1993).
24. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B. and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9, 935-944 (1995).
25. LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A. and Harlow, E. New functional activities for the p21 family of cyclin-dependent kinase inhibitors. Genes Dev., 11, 847-862 (1997).
26. El-Deiry, W. S., Tokino, T. Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. Waf1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
27. Bass, M., Crooks, P. A., Levi, H., Na Phuket, S. and Rosenthal, G. A. Large scale production and chemical characterization of the protective, higher plant allelochemicals: L-canavanine and L-canaline. Biochem. Ecol. System, 23, 717-721 (1995).
28. Lehman, T. A., Bennett, W. P., Metcalf, R. A., Welsh, J. A., Ecker, W. J., Modali, R. V., Ullrich, S., Romano, J. W., Appella, E., Testa, J. R., Gerwin, B. I. and Harris, C. C. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res., 51, 4090-4096 (1991).
29. Okamoto, A., Hussain, S. P., Hagiwara, K., Spillare, E. A., Rusin, M., Demetrick, J., Serrano, M., Hannon, G. J., Shiseki, M., Zariwala, M., Xiong, Y., Beach, D. H., Yokota, J. and Harris, C. C. Mutations in the p161NK4/ MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55, 1448-1451 (1995).
30. Sambrook, J., Fritsch, E. F. and Maniatis, T. "Molecular Cloning: A Laboratory Manual," Ed. 2 (1989). Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
31. Sugano, T., Nitta, M., Ohmori, H. and Yumuizumi, M. Nuclear accumulation of p53 in normal human fibroblasts is induced by various cellular stresses which evoke the heat shock response, independently of the cell cycle. Jpn. J. Cancer Res., 86, 415-418 (1995).
32. Forrester, K., Ambs, S., Lupold, S. E., Kapust, R. B., Spillare, E. A., Weinberg, W. C., Felley-Bosco, E., Wang, X. W., Geller, D. A., Tzeng, E., Billiar, T. R. and Harris, C. C. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. USA, 93, 2442-2447 (1996).
33. Meßmer, U. K., Ankarcrona, M., Nicotera, P. and Brüne, B. P53 expression in nitric oxide-induced apoptosis. FEBS Lett., 355, 23-26 (1994).